Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $6.3150 (-0.63%) ($6.3150 - $6.3150) on Tue. Mar. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.99% (three month average) | RSI | 36 | Latest Price | $6.3150(-0.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.1% a day on average for past five trading days. | Weekly Trend | IOVA declines -4.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) XBI(47%) IBB(34%) ACES(25%) IWC(24%) ARKG(22%) | Factors Impacting IOVA price | IOVA will decline at least -1.995% in a week (0% probabilities). BND(-13%) XLP(-12%) UUP(-12%) VXX(-11%) VIXM(-10%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.995% (StdDev 3.99%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-3.78(-159.86%) | Resistance Level | $6.85 | 5 Day Moving Average | $6.51(-3%) | 10 Day Moving Average | $6.53(-3.29%) | 20 Day Moving Average | $6.85(-7.81%) | To recent high | -23.4% | To recent low | 12.6% | Market Cap | $925m | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |